data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Ardelyx
(NASDAQ:ARDX)
$0.6082
0.0142[2.39%]
Last update: 12:46PM
Day High/Low0.57 - 0.62
52 Week High/Low0.49 - 8.25
Open / Close0.57 / -
Float / Outstanding143.1M / 144.6M
Vol / Avg.1.1M / 3.6M
Mkt Cap87.9M
P/E-
50d Avg. Price0.68
Div / Yield-
Payout Ratio-
EPS-0.21
Total Float143.1M

Ardelyx (NASDAQ:ARDX), Quotes and News Summary

Ardelyx (NASDAQ: ARDX)

Day High/Low0.57 - 0.62
52 Week High/Low0.49 - 8.25
Open / Close0.57 / -
Float / Outstanding143.1M / 144.6M
Vol / Avg.1.1M / 3.6M
Mkt Cap87.9M
P/E-
50d Avg. Price0.68
Div / Yield-
Payout Ratio-
EPS-0.21
Total Float143.1M
Benzinga - 5 days ago
Benzinga - Jun 21, 2022, 8:03AM
Benzinga - May 24, 2022, 4:02PM
Benzinga - May 19, 2022, 6:46AM
Benzinga - May 17, 2022, 4:02PM
Benzinga - May 6, 2022, 5:48AM
Benzinga - May 5, 2022, 4:33PM
Benzinga - Apr 25, 2022, 11:38AM
Benzinga - Apr 25, 2022, 11:20AM
Benzinga - Apr 25, 2022, 10:23AM
Benzinga - Apr 25, 2022, 7:01AM
Benzinga - Apr 11, 2022, 1:14PM
Benzinga - Apr 11, 2022, 7:13AM
Benzinga - Apr 7, 2022, 8:06AM
Benzinga - Apr 4, 2022, 11:15AM
Benzinga - Apr 4, 2022, 8:10AM
Benzinga - Mar 2, 2022, 1:54PM
Sector: Health Care.Industry: Biotechnology
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-12
REV
Q1 2022Est.ActualSurprise
EPS-0.220-0.210 0.0100
REV870.000K468.000K-402.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Ardelyx Questions & Answers

Q
How do I buy Ardelyx (ARDX) stock?
A

You can purchase shares of Ardelyx (NASDAQ: ARDX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Ardelyx's (ARDX) competitors?
Q
What is the target price for Ardelyx (ARDX) stock?
A

The latest price target for Ardelyx (NASDAQ: ARDX) was reported by Piper Sandler on Thursday, May 19, 2022. The analyst firm set a price target for 3.00 expecting ARDX to rise to within 12 months (a possible 393.26% upside). 9 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Ardelyx (ARDX)?
A

The stock price for Ardelyx (NASDAQ: ARDX) is $0.6082 last updated Today at July 5, 2022, 4:46 PM UTC.

Q
Does Ardelyx (ARDX) pay a dividend?
A

There are no upcoming dividends for Ardelyx.

Q
When is Ardelyx (NASDAQ:ARDX) reporting earnings?
A

Ardelyx’s Q2 earnings are confirmed for Friday, August 12, 2022.

Q
Is Ardelyx (ARDX) going to split?
A

There is no upcoming split for Ardelyx.

Q
What sector and industry does Ardelyx (ARDX) operate in?
A

Ardelyx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.